Substance

NATALIZUMAB

Global reference: every product and company linked to this substance.

AN100226M · ANTEGRAN · natalizumab [INN] · NATALIZUMAB [JAN] · NATALIZUMAB [USAN] · Natalizumab [WHO-DD] · NATALIZUMAB ELAN PHARMA · TYSABRI

Revenue by product (0)

No revenue reported for this substance in loaded filings.

A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.

Products containing this substance (1)

  • TYSABRI · BIOGEN INC. COMMON STOCK

Companies holding this asset (1)